RT101（Regel Therapeutics）

N/A

Report date: 2023/03/17 13:21:55

Base Information

Drug NameRT101（Regel Therapeutics）
Drug Alias NameRT101RT-101
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene expression modulatorsSodium channel protein type II alpha subunit blockers
TargetsSodium channel protein type II alpha subunit
Therapy Area/IndicationsEpilepsies, Myoclonic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRegel Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesRegel Therapeutics
Inactive CompaniesN/A
Active IndicationsEpilepsies, Myoclonic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A